Central Fos expression and conditioned flavor avoidance in rats following intragastric administration of bitter taste receptor ligands.
G protein-coupled receptors that signal bitter taste (T2Rs) are expressed in the mucosal lining of the oral cavity and gastrointestinal (GI) tract. In mice, intragastric infusion of T2R ligands activates Fos expression within the caudal viscerosensory portion of the nucleus of the solitary tract (NTS) through a vagal pathway (Hao S, Sternini C, Raybould HE. Am J Physiol Regul Integr Comp Physiol 294: R33-R38, 2008). The present study was performed in rats to further characterize the distribution and chemical phenotypes of brain stem and forebrain neurons activated to express Fos after intragastric gavage of T2R ligands, and to determine a potential behavioral correlate of this central neural activation. Compared with relatively low brain stem and forebrain Fos expression in control rats gavaged intragastrically with water, rats gavaged intragastrically with T2R ligands displayed significantly increased activation of neurons within the caudal medial (visceral) NTS and caudal ventrolateral medulla, including noradrenergic neurons, and within the lateral parabrachial nucleus, central nucleus of the amygdala, and paraventricular nucleus of the hypothalamus. A behavioral correlate of this Fos activation was evidenced when rats avoided consuming flavors that previously were paired with intragastric gavage of T2R ligands. While unconditioned aversive responses to bitter tastants in the oral cavity are often sufficient to inhibit further consumption, a second line of defense may be provided postingestively by ligand-induced signaling at GI T2Rs that signal the brain via vagal sensory inputs to the caudal medulla.
Hao
Shuzhen
S
Vet Med: APC, 1330 Haring Hall, UC Davis, Davis, CA 95616, USA.
Dulake
Michelle
M
Espero
Elvis
E
Sternini
Catia
C
Raybould
Helen E
HE
Rinaman
Linda
L
D000679:Amygdala / Q000502:physiology; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D016762:Genes, fos / Q000187:drug effects*; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D007441:Intubation, Gastrointestinal; D008024:Ligands; D008297:Male; D009434:Neural Pathways / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D011441:Propylthiouracil / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D043562:Receptors, G-Protein-Coupled / Q000187:drug effects*; D013649:Taste / Q000187:drug effects*; D000098706:Taste Receptors, Type 2
D008024:Ligands; D009638:Norepinephrine; D011441:Propylthiouracil; D000644:Quaternary Ammonium Compounds; D043562:Receptors, G-Protein-Coupled; D000098706:Taste Receptors, Type 2; C043414:denatonium